Scientists are seeking a treatment, referred to as an "anti-Ozempic", to address weight loss in cancer patients. The goal of this treatment is to encourage weight gain. It is unclear what form this treatment will take, with one potential approach involving a cannabis-based drug that stimulates appetite.